The impact of diabetes mellitus on penile length in men undergoing inflatable penile prosthesis implantation Diabetes mellitusun şişirilebilir penil protez uygulanan erkeklerdeki penis boyu üzerine etkisi

Materials and methods: Between April 2000 and December 2012, we retrospectively investigated data from patients who were diagnosed with organic ED and performed penile prosthesis implantation (PPI). Of the 239 patients, 235 patients were included in the study. Four patients who were operated on for transsexuality were excluded from the study. All patients were divided into two groups; group 1 included patients with DM, and group 2 included patients without DM. Data, including age, body mass index (BMI) in kg/ m2, operation history, comorbidities, International Index of Erectile Function (IIEF) questionnaire results, combined intracavernous injection and stimulation (CIS) test results, the measured length of the corpus cavernosum while implanting the penile prosthesis, complications, operation time, mean hospital stay, and the satisfaction of the patient and partner, were recorded. Kruskal-Wallis and Mann-Whitney U tests were used for statistical analysis. A p-value of <0.05 was considered to be statistically significant.